Sandbox:UT: Difference between revisions
Jump to navigation
Jump to search
Usama Talib (talk | contribs) No edit summary |
Usama Talib (talk | contribs) |
||
| Line 18: | Line 18: | ||
* Medications like [[Zoloft]], [[isotretinoin]], some [[antihypertensive]] agents(e.g [[thiazides]]), [[tamoxifen]] <ref name="pmid16672684">{{cite journal| author=Pejic RN, Lee DT| title=Hypertriglyceridemia. | journal=J Am Board Fam Med | year= 2006 | volume= 19 | issue= 3 | pages= 310-6 | pmid=16672684 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16672684 }} </ref> | * Medications like [[Zoloft]], [[isotretinoin]], some [[antihypertensive]] agents(e.g [[thiazides]]), [[tamoxifen]] <ref name="pmid16672684">{{cite journal| author=Pejic RN, Lee DT| title=Hypertriglyceridemia. | journal=J Am Board Fam Med | year= 2006 | volume= 19 | issue= 3 | pages= 310-6 | pmid=16672684 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16672684 }} </ref> | ||
* Nephrotic syndrome <ref name="pmid2002630">{{cite journal| author=Appel G| title=Lipid abnormalities in renal disease. | journal=Kidney Int | year= 1991 | volume= 39 | issue= 1 | pages= 169-83 | pmid=2002630 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2002630 }} </ref> | * Nephrotic syndrome <ref name="pmid2002630">{{cite journal| author=Appel G| title=Lipid abnormalities in renal disease. | journal=Kidney Int | year= 1991 | volume= 39 | issue= 1 | pages= 169-83 | pmid=2002630 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2002630 }} </ref> | ||
*hypothyroidism | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 19:06, 8 November 2016
Hypertriglyecridemia/Secondary Hypertriglyceridemia
Classification
- As primary or secondary to another cause that can be obesity, diabetes type 2 or excessive alcohol consumption[1]
Causes
Secondary Hypertriglyceridemia
- A diet high in carbohydrate content [2] [3]
- A diet high in fat content [4]
- Idiopathic
- Obesity [1]
- Diabetes mellitus[1]
- Metabolic Syndrome [5]
- Paraproteinemic disorders
- Alcohol use [1]
- Estrogen therapy [4]
- Use of glucocorticoids [4]
- Medications like Zoloft, isotretinoin, some antihypertensive agents(e.g thiazides), tamoxifen [4]
- Nephrotic syndrome [6]
- hypothyroidism
References
- ↑ 1.0 1.1 1.2 1.3 Yuan G, Al-Shali KZ, Hegele RA (2007). "Hypertriglyceridemia: its etiology, effects and treatment". CMAJ. 176 (8): 1113–20. doi:10.1503/cmaj.060963. PMC 1839776. PMID 17420495.
- ↑ Silva ME, Pupo AA, Ursich MJ (1987). "Effects of a high-carbohydrate diet on blood glucose, insulin and triglyceride levels in normal and obese subjects and in obese subjects with impaired glucose tolerance". Braz J Med Biol Res. 20 (3–4): 339–50. PMID 3330460.
- ↑ McCarty MF (2004). "An elevation of triglycerides reflecting decreased triglyceride clearance may not be pathogenic -- relevance to high-carbohydrate diets". Med Hypotheses. 63 (6): 1065–73. doi:10.1016/j.mehy.2002.11.002. PMID 15504577.
- ↑ 4.0 4.1 4.2 4.3 Pejic RN, Lee DT (2006). "Hypertriglyceridemia". J Am Board Fam Med. 19 (3): 310–6. PMID 16672684.
- ↑ Ford ES, Giles WH, Dietz WH (2002). "Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey". JAMA. 287 (3): 356–9. PMID 11790215.
- ↑ Appel G (1991). "Lipid abnormalities in renal disease". Kidney Int. 39 (1): 169–83. PMID 2002630.